We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Throwing their weight around

27 October 2003 By Robert Cyran

It will be a powerful counterweight to big pharma, potentially driving down drug prices which are higher in the US than elsewhere. Anthem’s $15bn acquisition of WellPoint will create a behemoth controlling health spending for 9% of the US population.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)